Books > Medicine > General issues
|
Buy Now
ACE Inhibitors (Paperback, Softcover reprint of the original 1st ed. 2001)
Loot Price: R1,450
Discovery Miles 14 500
|
|
ACE Inhibitors (Paperback, Softcover reprint of the original 1st ed. 2001)
Series: Milestones in Drug Therapy
Expected to ship within 10 - 15 working days
|
Angiotensin converting enzyme inhibitors (ACEI) represent the first
class of antihypertensive agents that was designed and developed on
the basis of a well-defined physiopathological axis of arterial
hypertension, a vascular dis order that is now becoming one of the
major causes of morbidity/mortality, not only in developed
societies but also in the highly populated developing coun tries
[1]. CAPTOPRIL, the prototype of the "PRIL" family, which now
comprises more than 40 molecule-species, was quite hazardous and
the clinical develop ment almost failed when serious side-effects
were reported in an alarmist fash ion in reputable scientific
journals, such as the New England Journal of Medicine and Lancet.
Squibb & Sons came very close to withdrawing CAPTOPRIL from
clinical investigation [2]. However, after re-examination of the
data obtained from different categories of patients and appropriate
dose-adjustments, the clinical use of CAPTOPRIL turned out to be
revolutionary. The prototype, as well as other members of the
"PRIL" family became the starting point for numerous basic and
clinical research programs, focusing on the interactions of ACEI
with the kinin, endothelin, and nitric oxide systems, and the
contribution of the receptors for AT I, AT 2, bradykinin Bland B ,
ETA and ET B to the pharmacological actions 2 of the respective
peptides. This research activity led to the development of new
pharmacological agents, such as the angiotensin receptor
antagonists and, more recently, the neutral endopeptidase
inhibitors. In the near future, bradykinin receptor antagonists
also will be available to modulate ACEI phar macological actions.
General
Imprint: |
Springer Basel
|
Country of origin: |
Switzerland |
Series: |
Milestones in Drug Therapy |
Release date: |
September 2012 |
First published: |
2001 |
Editors: |
Pedro D'Orleans-Juste
• G.E. Plante
|
Dimensions: |
244 x 170 x 10mm (L x W x T) |
Format: |
Paperback
|
Pages: |
187 |
Edition: |
Softcover reprint of the original 1st ed. 2001 |
ISBN-13: |
978-3-03-487581-3 |
Categories: |
Books >
Medicine >
General issues >
General
|
LSN: |
3-03-487581-9 |
Barcode: |
9783034875813 |
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
You might also like..
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.